Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
about
Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Study protocol for a multi-ins ...... apentinoids: the DIRECT study.
@en
type
label
Study protocol for a multi-ins ...... apentinoids: the DIRECT study.
@en
prefLabel
Study protocol for a multi-ins ...... apentinoids: the DIRECT study.
@en
P2093
P2860
P1433
P1476
Study protocol for a multi-ins ...... apentinoids: the DIRECT study.
@en
P2093
Atsuko Koyama
Hiromichi Matsuoka
Hiroto Ishiki
Keisuke Ariyoshi
Satoru Iwase
Takashi Kawaguchi
Takuhiro Yamaguchi
Tatsuya Morita
Tempei Miyaji
Yoshinobu Matsuda
P2860
P304
P356
10.1136/BMJOPEN-2017-017280
P577
2017-08-28T00:00:00Z